Topical process for treating herpes infections using 5-isopropyl-2'-.beta.- d
US4880785A · kind A · utility
1Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1988 |
| Grant date | Nov 14, 1989 |
| Priority date | — |
| Expiry date | Jun 10, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an externally applicable, antiviral pharmaceutical composition accumulating in the skin for treating herpes infections, which composition comprises 0.2-5% by mass of 5-isopropyl-2'-.beta.-deoxyuridine admixed with carriers, diluents and/or other additives conventionally used in the production of pharmaceutical compositions for external use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.